Compiling observations and administration of Golden Sunrise Nutraceutical products should always be under the supervision of a licensed physicians, registered nurse, and medical specialists in the medical field. Recommendations for Golden Sunrise Nutraceutical products are based on the following criteria; Medical evaluation, assessment, diagnoses, monitoring, and medical report results of the patient. Evidence-Based Care is a set of principles and methods intended to ensure that to the greatest extent possible thru best clinical judgments or medical decisions are made.
CANCER CASE REPORTS
1.1. Patient with Pancreatic Cancer
G.T. is a 71-year-old Hispanic male was that diagnosed with stage four pancreatic cancer on May 03, 2025, Cancer Antigen 19-9 (CA 19-9) level at 162-Ul/mL and found the pancreatic cancer has spread throughout his body. Patient blood report results on April 29, 2025 through April 30, 2025; Glucose level 210-mg/dL, Creatinine level 0.75-mg/dL, Bilirubin level 4.7-mg/dL, Alkaline Phosphatase level 1050-IU/L, AST level159-IUL, ALT level 155-IU/L. Patient complained of lower back pain, increasingly constipated, fatigued, and depressed at the diagnosis. Patient had been going to California Los Angeles Hospital (Hospital) and was being prepared fro chemotherapy treatment. Patient did not want to take chemotherapy treatment as he witnessed his friends and family receive chemotherapy treatments without successful outcomes. Patient heard of Golden Sunrise Nutraceutical Cancer Treatment (Cancer Treatment) through his family and set up an appointment with Mrs. Fontana at Oakview Medical Group. Patient agreed to try Cancer Treatment and him and his family left chemotherapy treatment on the table if Cancer Treatment was unsuccessful. Mrs. Fontana discussed his option and prescribed Cancer Treatment for him on May 17, 2025. Results: Patient was prescribed Cancer Treatment, shortly after patient was taking Cancer Treatment he could have a Bowel Movement (BM) and after this he steadily improved his BM's to 3-times per day. After a month patient energy levels noticeably health improved where he could walk outside and water plants. Patient depression no longer was an issue, his back pain which he claimed he suffered from for many years no longer was an issue, recovery continued health improve, mental clarity, and none of the previous issues were of note by this time. After Cancer Treatment there was taken a complete blood report results on May 08, 2025, and found that patient Glucose levels had decreased from 210-mg/dL to 188-mg/dL, Creatinine levels had decreased from 0.75-mg/dL to 0.56-mg/dL, Bilirubin levels had decreased from 4.7-mg/dL to 1.3-mg/dL, ALkaline Phosphatase levels had decreased from 1050-IU/L to 475-IU/L, AST levels had decreased from 150-IU/L to 47-IU/L, and ALT levels had decreased from 155-IU/L to 58-IU/L. Patient after four weeks was prescribed by Mrs. Fontana of Cancer Treatment. On May 08, 2025 patient then went back to UCLA Medical to update for the blood report results and discuss options for chemotherapy treatment. The oncologist at Hospital said to hold off on the chemotherapy treatment and then patient panning to go on vacation. Patient family planed for him to go to Mexico and enjoy a relaxing time. Before Cancer Treatment his family expected patient to be bedridden due to the debilitating effects of the cancer or disease. After Cancer Treatment patient family says they see his health conditions improving every day since Cancer Treatment was begun, he has more energy to work in his garden. On June 28, 2025 patient son said that his father cough had been reduced and patient was walking more. Patient son said previous day he walked 12,000-steps. On July 15, 2025 through July 21, 2025 Glucose levels had decreased from 253-mg/dL to 211-mg/dL, Creatinine in normal range from 0.80-mg/dL to 1.30-mg/dL, Alkaline Phosphatase in normal range from 98-IU/L to 96-IU/L, AST in normal range from 28-IU/L to 30-IU/L, and ALT in normal range from 23-IU/L to 25-IU/L.
1.2. Patient with Prostate Cancer
C.S. is an 83-year-old white male that was diagnosed with prostate cancer on October 10, 2024. Prostate-Specific Antigen (PSA) level was at 13-ng/ml and he complained of an increase feeling of being tired all the time and had no energy function in day-to-day tasks. After patient diagnosis he was asked to take chemotherapy treatment by his initial physician but refused. Patient was looking for alternative therapies and wished to use herbal, botanical, or nutritional alternatives. Patient heard Golden Sunrise Nutraceutical Cancer Treatment (Cancer Treatment) and consented to take Cancer Treatment. Patient had said if Cancer Treatment would prolong his life and give himself good for three years quality-of-life, feeling well, and he would be happy with it. The Cancer Treatment was administered by Oakview Medical Group under the supervision of Sonja I FONTANA (Mrs. Fontana), CPC-FNP-C. Results: On November 05, 2024 patient was tested again and his PSA levels had decrease from 13-ng/mL to 9.6-ng/mL. Patient again said he had more energy to do whatever he wanted and was very happy with the results from Cancer Treatment and he will continue the Cancer Treatment. Patient went to his oncologist for an update as to his prostate cancer on May 10, 2025. The oncology doctor had been pushing him to get chemotherapy treatment. When the patient talked with the oncologist, doctor said no action was needed as his prostate cancer was not progressing. The oncologist had received blood report results that showed patient improvement and did not want to move forward with any chemotherapy treatment and said to keep doing what you are doing.
1.3. Patient with Colon Cancer
J.O. is a 45-year-old white male was that diagnosed with advanced stage four colon cancer on January; 2016. After the initial consultation Golden Sunrise Nutraceutical Cancer Treatment (Cancer Treatment) patient didn't want Cancer Treatment and began chemotherapy treatment. Patient received the first cycle of chemotherapy treatment on March; 2016. Patient symptoms included a damaged liver, renal obstruction, lung polyps, anxiety, depression, and severe lack of energy. After patient first round of chemotherapy treatment he came back and wanted Cancer Treatment of both chemotherapy treatment and Cancer Treatment. Patient received twenty-two rounds of chemotherapy treatment while taking Cancer Treatment. Results: in April; 2016 patient received his first dose of Cancer Treatment administered orally and patient showed noticeable improvement in overall health in minutes. Patient didn't lose his hair, constipation was reduce, he showed an improvement in energy levels as the next day he was playing basketball, mental focus, depression, anxiety improved noticeably, and his outlook on life was a positive hope. Patient's blood report results revealed that the White Blood Count (WBC) levels had increased from 5.70-10^3/uL to 6.70-10^3/uL and Platelet count levels had increased from 70-10^3/uL to 78-10^3/uL on April; 2017 through May; 2017. WBC levels had increased from 5.70-10^3/uL to 7.70-10^3/uL and Platelet count levels had increased from 70-10^3/uL to 187-10^3/uL on April; 2017 through November; 2017. Patient tumors have shrunk and since Cancer Treatment and chemotherapy treatment he has had no major side-effects such as hair loss, debilitating constipation, depression, anxiety, weight loss, or nausea. Patient has not had to visit the emergency for complications except for a staph infection. Patient is doing well and can function without interference with his normal lifestyle. Patient has been motivated to tell other cancer patients of the benefits of taking Cancer Treatment that it can help other patients with serious or Life-threatening illnesses.
1.4. Patient with Esophageal Cancer
R.H. is a 54-year-old white male that was diagnosed with esophageal cancer on December 26, 2016. Patient was rushed to the local emergency room where testing immediately began and the diagnosis was made. Patient's esophageal cancer progression was identified in stage two after patient collapsed for no apparent reason and began spewing blood. Patient refused standard medical chemotherapy treatment at Houston Texas Hospital (Hospital). Patient had pain in patient's knees for 20-years from playing professional Football, patient claimed that to sleep he would have to "Ice" on his knees to deal with the pain. Results: Patient began taking Golden Sunrise Nutraceutical Cancer Treatment (Cancer Treatment) on February 20, 2017 and showed improvements in blood report results; White Blood Count (WBC) levels had increased from 6.4-10^3/uL to 9.4-10^3/uL, Mean Platelet Volume levels had increased from 6.9-fL to 8.4-fL, and Platelet count levels had decreased from 375-10^3/uL to 332-10^3/uL on March 14, 2017. On March 21, 2017 patient had biopsies that were conducted and esophageal mucosal changes were noticed that was consistent with Barrett's esophagus. The physician at Hospital after reviewing both the blood report results and medical scan results recommended; "Resume regular diet" and "received another checkup in four weeks". Patient was referred back to primary care physician. No chemotherapy treatment was prescribed. Patient was observed with improved energy and reduction in pain, but after one month of Cancer Treatment the patient noticed the pain was gone and did not need to "Ice' on his knees anymore.
1.5. Patient with Lymphocytic Leukemia
M.B. is a 69-year-old white male that was diagnosed with chronic Lymphocytic Leukemia on August 17, 2010. Patient started taking Golden Sunrise Nutraceutical Cancer Treatment (Cancer Treatment) on October; 2015. This was because of the concern about falling Red Blood Count (RBC) and Platelet count. Patient White Blood Count (WBC), though elevated remained elevated, and fluctuant. Results: On October; 2015 through April; 2016, patient RBC levels had increased from 4.05-10^3/uL to 4.19-10^3/uL and Platelet count levels had increased from 90-10^3/uL to 105-10^3/uL. It was that this was significant increase in both patient RBC and Platelet count.
1.6. Patient with Liver Cancer
T.B. is a 72-year-old white male that was diagnosed with stage four liver cancer on July; 2006. Patient complained of excruciating pain and could not find relief from any source of medication or alternative treatment. Results: Patient began taking Golden Sunrise Nutraceutical Cancer Treatment (Cancer Treatment) and in matter of days the pain had subsided. On December; 2007 through February; 2008, patient Alkaline Phosphatase levels had decreased from 163-IU/L to 120-IU/L, AST levels had decreased from 46-IU/L to 31-IU/L, and ALT levels had decreased from 68-IU/L to 35-IU/L.
1.7. Patient with Brain Tumor
V.A. is a 7-year-old Hispanic male that was diagnosed Central Neurocytoma Gadolinium (Brain Tumor) on April 04, 2007 with a left intraventricular tumor and obstructive hydrocephalus. Patient had received nine cycles of chemotherapy treatment, radiation, and surgery at Fresno California Hospital. The chemotherapy treatment, radiation, and surgery left the patient weak and unable to get out and play, he couldn't sleep and had seizures up to about ten times daily. Patient didn't believe he had a chance to live because the oncologist said that patient had an infection in his brain which was of grave concern and gave no hope for the patient to survive (the doctors had told patient no patient survives more than eleven months with a brain tumor, then the patient's aunt heard of Golden Sunrise Nutraceutical Cancer Treatment (Cancer Treatment) and that this could help her nephew. Mother of the patient called Golden Sunrise Nutraceutical (Golden Sunrise) to help her son and Golden Sunrise medical staff came to there house and treated the patient with Cancer Treatment on January 05, 2008. Results: Patient received the Cancer Treatment about and in 10-minutes, the patient started feeling nauseous, and started sweating then after 20-minutes he started vomiting for a few minutes after the patient finished vomiting he asked for water he drank six glasses of water back to back then the patient put his hand on his heart and said I'm happy here then he patted his hand on his head and said I'm happy here with alertness, then patient ran out the door, and started to play. The patient ran around the front yard and played for at least an hour. On August 14, 2008 Magnetic Resonance Imaging (MRI) scan report Findings: There is no convincing evidence for leptomeningeal enhancement on post-contrast sagittal T1-weighted images. Impression: No convincing evidence for residual or recurrent tumor. On March 05, 2009 MRI Cervical, Thoracic, Lumber scan report Findings: There is no convincing evidence for leptomeningeal tumor in the cal sac or on the surface of the spinal cord. Some faint dark signal at the tip of the cal sac is again noted but this is not pathognomic of tumor. No overt enhancement of the tip of the cal sac is noted. Impression: No convincing evidence for recurrent tumor. On March 05, 2009 MRI Brain WITH 70553 scan report Findings: No mass lesions are noted in the frontal horns of either lateral ventricle and no abnormal leptomeningeal enhancement is noted elsewhere. The ventricles are slightly prominent but stable compared with the last study. The visualized vascular structures are within normal limits. Artifact from the shunt system in the right transverse sinus region is noted. Impression: Post-therapy changes including leukoencephalopathy in the frontal lobes bilaterally, and in both cerebellar hemispheres. There is no convincing evidence for recurrent, residual, or metastatic. On June 04, 2009 MRI Brain WITH 70553 scan report Findings: The non-enhancing deep white matter hyperintensities within both cerebral hemispheres are stable. Non-enhancing hyperintensities within the central portions of both cerebellar hemispheres are also stable. These changes may be related to the effect of prior therapy. There is no evidence of restricted diffusion. Impression: There are no changes to suggest progressive infection. Diffuse dural thickening and enhancement is stable. Patient had completed high school and wants to go to college.
1.8. Patient with Breast Cancer
J.P. is a 44-year-old white female that was diagnosed with stage I breast cancer on December; 2018 and was found with a lump. The patient had refused Chemotherapy treatment, radiotherapy, and surgery and only interested in trying alternative approaches to treating her cancer. The patient had heard of Golden Sunrise Nutraceutical (Golden Sunrise) and contacted the medical director. The patient was medically evaluated and Golden Sunrise Cancer Treatment (Cancer Treatment) was begun in February 10, 2019. Results: The patient received Cancer Treatment for approximately 5-months until was found that the patient was in remission. On July 31, 2019 the lymph node ultrasound results are clear and cryoablation went well on July 31, 2019. Insurance company evaluated the Cancer Treatment and medical report results that actual treatments and then proceeded to cover the costs of the Cancer Treatment.
DIABETES CASE REPORTS
1.9. Patient with Type 1 Diabetes
N.O. is a 20-year-old white male that was diagnosed with Type 1 Diabetes on February; 2011. Patient requires lifelong insulin injections daily to manage his blood glucose levels. Patient's diet is restrictive though the patient rarely follows his diet regiment. Patient started with Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on May 10, 2019. Results: After the patient was administered the Metabolic Treatment, the patient was then monitored by medical staff for a response. After a short period of time the patient's blood glucose levels showed a significant decrease from 440-mg/dL to 60-mg/dL in less than two hours without the patient experiencing any symptoms such as dizziness, weakness, sweating, the patient did not demonstrate any adverse-effects, etc., and still carry on the usual daily activities.
MULTIPLE SCLEROSIS CASE REPORTS
1.10. Patient with Multiple Sclerosis (MS)
E.B. is a 46-year-old white male that was diagnosed with Multiple Sclerosis (MS) in June; 2003. Patient was first suspected as having lime disease but upon further testing it was found to be MS, patient experienced almost total immobility of legs, arms. What mobility there was, showed extreme spasmodic function, and continual degradation of motor function until he was bedridden. Patient blood report results on September 06, 2017 showed a White Blood Count (WBC) 6.04-Thousand/UL and Platelet count 206-Thousand/UL. Patient was debilitated from the beginning and wasn't responding to prescription drugs, so patient did three rounds of chemotherapy treatment to stop the progression. Patient was able regain quite a bit of his function, but experienced significant pain. Patient was in a significant amount of pain despite being on multiple heavy pain medications. On November 01, 2016 patient ended up in the Hospital for twenty-four hours, due to complications of his MS. When the patient came home from the Hospital he was now bed bound and completely dependent. Results: Patient began taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on October 04, 2017. A positive response to a first dose of Metabolic Treatment is generally a good sign, indicating the Metabolic Treatment is having effectiveness this refers to Real-World Evidence. Over the course of Metabolic Treatment the patient has experienced improved motor function to where he can sit in a wheelchair, move himself and can sit on the toilet without the aid of the caregiver. Patient continues to show marked improvement as the Metabolic Treatment progresses, the WBC results and Platelet count results show improvement supporting the physical observations. On December 06, 2017 WBC levels had increased from 6.04-Thousand/UL to 9.60-Thousand/UL and Platelet count levels had increased from 206-Thousand/UL to 254-Thousand/UL. In December; 2018 patient is off all his pain medications and patient is no longer on his MS medications including high doses of eight plus medications. Within a year the patient taking Metabolic Treatment has cognitive function returned, he can talk, and eat again. Patient's limbs function are return in after Metabolic Treatment and now with physical therapy he has been able to walk assisted small distances, Patient is able to stand for a short time, and quality-of-life has significantly improved. Patient previous prescription drug costs for Medicare were around ninety-six thousand ($96,000.00) dollars per year. On February; 2019 patient prescription drug costs are reduced around two thousand ($2,000.00) dollars per year.
SEIZURES DISORDER CASE REPORTS
1.11. Patient with Seizures Disorder
A.V. is an 8-year-old Hispanic male with severe global development delays, seizures, a history of recurrent rhabdomyolysis, status post resection of a left temporal epidermoid cyst, brain biopsy, and the patient began to develop seizures around the age of 3-year-old. Mom states that during the seizures, the eyes, eyelids dropped down, and that has seizures 30-times per day. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on June 23, 2008. Results: After Metabolic Treatment, Outpatient Consultation on September 12, 2008 through September 24, 2008 the patient mom reports to the doctor that her son's seizures have been doing much better with only about two seizures per week and none of them particularly severe. The seizures are primarily drop seizures. They are brief. They are not tonic-clonic in nature. Patient is being managed currently on no seizure medications. The Metabolic Treatment is effective in reducing the frequency of his seizures.
1.12. Patient with Seizure Disorder
K.A. is an 8-year-old Hispanic female that was diagnosed with symptoms of recurrent episodes suggestive of seizures on May 21, 2012, with repetitive eye blinking, brief zoning out, starting change in speech, and after this patient resumes ongoing activity. Patient was physician referred to Golden Sunrise Nutraceutical (Golden Sunrise) after the physician could not improve patient condition. Patient started taking Golden Sunrise Metabolic Treatment (Metabolic Treatment) on September 17, 2012. Results: After Metabolic Treatment, the patient noticed improved mental clarity and improved focus. Later, her teacher observed a dramatically improved focus and mental clarity. The seizure from RECURRENT EPISODES decreased to become a dramatically IMPROVED FOCUS and MENTAL CLARITY. Patient is being managed currently on no seizure prescription drugs.
LYME DISEASE CASE REPORTS
1.13. Patient with Lyme Disease
L.G. is a 51-year-old white female that was diagnosed with late-stage Lyme disease on August 10, 2010 Immunoglobulin G (IgG) test results; POSITIVE and on October 21, 2010 Immunoglobulin M (IgM) test results; POSITIVE. Patient symptoms; Daily headaches, frequent migraines, weight gain, brain fog, depression, anxiety, moderate to severe fatigue, moderate chronic pain, intermittent tremors, and memory loss. Patient undergoing various prescription drugs for over six years with eighteen different medications and IV antibiotics twice a day for a year, patient was told her specialist physicians they could offer no more hope. It was then an Registered Nurse (RN) who had seen great results from Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) from her patients suffering from other ailments and conditions or diseases, including cancer the RN suggested patient try Metabolic Treatment. Patient set up an appointment with Mrs. Fontana at Oakview Medical Group, she agreed to try the Metabolic Treatment, and patient started taking Metabolic Treatment on October 31, 2018. Results: After Metabolic Treatment, the patient went from barely functioning and being bedridden to working back toward a meaningful, productive life, and felt well. On August 10, 2010 through September 25, 2019 IgG blood serum from a POSITIVE result to become a NEGATIVE result and IgM blood serum from a POSITIVE result to become a NEGATIVE result. Patient was treated with Metabolic Treatment and the patient has recovered. Patient symptoms are being managed without prescription drugs.
HEPATITIS C CASE REPORTS
1.14. Patient with Hepatitis C
H.J. is a 59-year-old white female that was diagnosed with chronic Hepatitis C infection on May; 1990. The patient was constantly being admitted to the Emergency for Life-threatening situations. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on November 22, 2010. Blood test for HCV RNA quantification using PCR measures the amount of Hepatitis C virus; 28,800,000-IU/mL and 7.46-log IU/mL on January 19, 2011. Results: Patient was administered the Metabolic Treatment and immediately demonstrated a pronounced positive response alertness. The patient noticed an increase in the blood flow throughout her the body, an increase in energy, mental clarity, skin pigmentation, she had a feeling of well-being, and a release of anxiety. After Metabolic Treatment, patient rarely going to emergency room. On January 19, 2011 through March 08, 2012 HCV RNA quantification using PCR measures the amount of Hepatitis C virus levels had decreased from 28,800,000-IU/mL to 3,485,375-IU/mL and HCV-RNA levels had decreased from 7.46-log IU/mL to 6.54-log IU/mL.
References
[1] Tieu, H. and Loeffler, M. (2022) Life Is Quantum Biology Effects Explained from the Schrodinger Equation, Serious or Life-threatening Conditions or Diseases, and COVID-19 Results. Journal of Biosciences and Medicines, DOI No.: 10.4236/jbm.2022.1010013.
[2] Tieu, H. and Loeffler, M. (2023) Tieu Equation Experimentation of Understanding by Energy Transfer Quantum Mechanics. Natural Science, DOI No.: 10.4236/ns.2023.153008.
[3] Huu S. Tieu & Martin F. Loeffler Volume 23 Issue 4 Version 1.0 Year 2023 Particle Becomes Energy = Energy Becomes Mass. ISSN No.: 2249-4626 & ISSN No.: 0975-5896 Global Journal of Science Frontier Research: A Physics and Space Science.
[4] Tieu, H. and Loeffler, M. (2023) Patient Quality-of-Life, Providers with Incentive Payments, Real-World Evidence, and Reducing Healthcare Costs through New Innovations. Health, DOI No.: 10.4236/health.2023.154022.
Copyright © 2018 - 2025 Golden Sunrise Nutraceutical - All Rights Reserved.